Patent directory · USPTO A61K / A61P
Patents matching “Theravance Biopharma R&D IP, LLC”
252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11702415
Crystalline hydrate of a JAK inhibitor compound
granted -
US 11697648
Fused pyrimidine pyridinone compounds as JAK inhibitors
granted -
US 11691948
Crystalline freebase forms of a biphenyl compound
granted -
US 11673879
Substituted pyrimidines and methods of use
granted -
US 11667637
Fused imidazo-piperidine JAK inhibitors
granted -
US 11649209
Crystalline freebase forms of a biphenyl compound
granted -
US 11642339
Methods of treating symptoms of gastroparesis using velusetrag
granted -
US 11642332
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
granted -
US 11634413
Neprilysin inhibitors
granted -
US 11608354
Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
granted -
US 11596624
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted -
US 11590116
Substituted pyridines and methods of use
granted -
US 11547687
Neprilysin inhibitors
granted -
US 11548887
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted -
US 11484531
Methods for treating chronic obstructive pulmonary disease
granted -
US 11471442
Administration of gut-selective JAK3 inhibitor
granted -
US 11453668
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 11452723
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted -
US 11439641
Pyrimidine JAK inhibitors for the treatment of skin diseases
granted -
US 11420965
Pyrimidine compound as JAK kinase inhibitor
granted -
US 11390603
Crystalline forms of a biphenyl compound
granted -
US 11339160
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted -
US 11299492
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 11261197
Neprilysin inhibitors
granted